• English
    • Ελληνικά
    • Deutsch
    • français
    • italiano
    • español
  • français 
    • English
    • Ελληνικά
    • Deutsch
    • français
    • italiano
    • español
  • Ouvrir une session
Voir le document 
  •   Accueil de DSpace
  • Επιστημονικές Δημοσιεύσεις Μελών ΠΘ (ΕΔΠΘ)
  • Δημοσιεύσεις σε περιοδικά, συνέδρια, κεφάλαια βιβλίων κλπ.
  • Voir le document
  •   Accueil de DSpace
  • Επιστημονικές Δημοσιεύσεις Μελών ΠΘ (ΕΔΠΘ)
  • Δημοσιεύσεις σε περιοδικά, συνέδρια, κεφάλαια βιβλίων κλπ.
  • Voir le document
JavaScript is disabled for your browser. Some features of this site may not work without it.
Tout DSpace
  • Communautés & Collections
  • Par date de publication
  • Auteurs
  • Titres
  • Sujets

Factors associated with the development of superficial vein thrombosis in patients with varicose veins

Thumbnail
Auteur
Karathanos, C.; Exarchou, M.; Tsezou, A.; Kyriakou, D.; Wittens, C.; Giannoukas, A.
Date
2013
DOI
10.1016/j.thromres.2013.05.017
Sujet
Superficial vein thrombosis
Varicose veins
Thrombophilia
Hypercoagulable states
Protein S deficiency
Obesity
RECURRENT VENOUS THROMBOEMBOLISM
GENETIC RISK-FACTORS
FACTOR-V-LEIDEN
METHYLENETETRAHYDROFOLATE REDUCTASE
LOWER-LIMBS
DEEP VEINS
THROMBOPHLEBITIS
OBESITY
THROMBOPHILIA
PREVALENCE
Hematology
Peripheral Vascular Disease
Afficher la notice complète
Résumé
Introduction: Superficial vein thrombosis (SVT) is a common and controversial clinical entity. Recent studies have demonstrated that SVT should be seen as a venous thromboembolism (VTE). The objective of this study was to investigate the prevalence of thrombophilia defects and to estimate the role of age, sex and body mass index (BMI) in patients with varicose veins (VVs) and SVT. Materials and Methods: A total of 230 patients with VVs, 128 with, and 102 without SVT underwent thrombophilia testing included factor V Leiden, prothrombin G20210A, methylenetetrahydrofolate reductase and plasminogen activator inhibitor-1 mutations, protein C, protein S (PS), anti-thrombin III and plasminogen deficiencies and levels of A(2) antiplasmin, activate protein C resistance and lupus anticoagulant. According to Clinical-Etiology-Anatomy- Pathophysiology (CEAP) classification patients were categorized in two subgroups: moderate disease (C-2,C-3) and severe disease (C-4,C-5,C-6). Age and body mass index were also assessed. Results: The prevalence of thrombophilia defects was significantly higher in patients with moderate disease and SVT (p = 0.002). In the C-2,C-3 group, SVT was associated with PS deficiency (p = 0.018), obesity (p < 0.001), male gender (p = 0.047) and age (p < 0.001). There were no significant differences in patients with severe disease. Conclusions: Age, male sex, obesity and PS deficiency are factors associated with SVT development among patients with VVs having moderate disease (C-2,C-3). (C) 2013 Elsevier Ltd. All rights reserved.
URI
http://hdl.handle.net/11615/29109
Collections
  • Δημοσιεύσεις σε περιοδικά, συνέδρια, κεφάλαια βιβλίων κλπ. [19735]
htmlmap 

 

Parcourir

Tout DSpaceCommunautés & CollectionsPar date de publicationAuteursTitresSujetsCette collectionPar date de publicationAuteursTitresSujets

Mon compte

Ouvrir une sessionS'inscrire
Help Contact
DepositionAboutHelpContactez-nous
Choose LanguageTout DSpace
EnglishΕλληνικά
htmlmap